A population-based analysis in Ontario demonstrated a fivefold increase in spironolactone prescriptions among heart failure patients treated with angiotensin-converting enzyme inhibitors (ACEIs) following the publication of the RALES trial
SGLT2 inhibitors are now authorised for the treatment of chronic kidney disease and heart failure in individuals with or without T2DM [1, 2]
Gabapentin May Increase Appetite One way that gabapentin might affect weight loss with semaglutide is by increasing appetite
Track your consumption honestly If you are reducing but not eliminating alcohol, track what you actually drink versus what you think you drink
NICE guidance emphasises the importance of individualised risk assessment and regular review for patients with type 2 diabetes, particularly those with established cardiovascular disease
In response to oxidative stress, the antioxidative system, capable of scavenging ROS, undergoes upregulation as a defense mechanism